Hemofiltration in sepsis and septic shock: Where do we stand?

Intensivmedizin und Notfallmedizin

Volumn 35, Issue 3, 1998, Pages 228-234

  Rogiers, P ^a   Zhang, H ^b   Nagler, J ^a   Vincent, J L ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

H mofiltration; Septischer Schock; Zytokine

Indexed keywords

EID: 0001532449     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050141     Document Type: Article

References (57)

1. Andreasson S, Göthberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993; 56:1515-1517
2. Bagshaw ONT, Anaes FRC, Hutchinson A. Continuous arteriovenous hemofiltration and respiratory function in multiple organ systems failure. Intensive Care Med 1992; 18:334-338
3. Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Zeev IB. Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 1989; 17:634-637
4. Bellomo R. Continuous hemofiltration as blood purification in sepsis. New Horizons 1995; 3:732-737
5. Bellomo R, Farmer M, Wright Ch, Parkin G, Boyce N. Treatment of sepsis-associated acute renal failure with continuous hemodiafiltration: clinical experience and comparison with conventional dialysis. Blood Purif 1995; 13:246-254
6. Bellomo R, Mc Grath B, Boyce N. Effects of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure. Crit Care Med 1994; 22.833-837
7. Bellomo R, Tipping P, Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure 1995; 17:457-466
8. Böhm R, Gladziwa U, Clasen W, Riehl J, Mann H, Sieberth HG. Which bicarbonate concentration is adequate to lactate-buffered substitution fluids in maintenance hemofiltration? Clinical Nephrology 1994; 42:257-262
9. Böhrer H, Schmidt H, Bach A, Motsch J, Marti E. Removal of cytokines in septic patients using continuous venovenous hemodiafiltration (letter). Crit Care Med 1994; 4:717-718
10. Boulain T, Delpech M, Legras A, Lanotte R, P-F Dequin, Perrotin D. Continuous venovenous hemodiafiltration in acute renal failure associated with multiple organ failure: influence on outcome. Clin Int Care 1996; 7:4-10
11. Calandra T, Baumgartner JD, Grau DG, Wu MM, Lambert P-H, Schellekens J, Verhoef J, Glauser MP, and the Swiss-Dutch J5 Immunoglobulin Study Group. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 1990; 161:982-987
12. Cheadle WG, Hanasawa K, Gallinaro RN, Nimmanwudipong Th, Kodama M, Polk HC. Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis. Surgery 1991; 110:785-792
13. Cheung AK, Parker CJ, Wilcox LA, Janatova J. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophane. Kidney Int 1990; 37:1055-1059
14. Coraim FJ, Coraim HP, Ebermann R, Stellwag FM, Acute respiratory failure after cardiac surgery : clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 1986; 14:714-718
15. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-979
16. Di Carlo JV, Dudley TE, Sherbotie JR, Kaplan BS, Costarino AT. Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med 1990; 18:822-826
17. Druml W. Nonrenal indications for continuous hemofiltration therapy in patients with normal renal function? In: Sieberth HG, Stummvoll H, Kierdorf H (eds): Continuous extracorporeal treatment in multiple organ dysfunction syndrome. Contrib Nephrol. Basel, Karger, 1995; 116:121-129
18. Edwards JD, Brown GCS, Nightingale P, Slater RM, Faragher EB. The use of survivors1 cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 1989; 17:1098-1103
19. Elliott D, Wiles C, Reynolds H. Removal of cytokines in septic patients using continuous venovenous hemodiafiltration (letter). Crit Care Med 1994; 22:718-719
20. Fisher C. Clinical trials of immunotherapy for sepsis. Crit Care Med 1992; 20:721-723
21. Freeman BD, Yatsiv I, Natanson C, Solomon MA, Quezado ZMN, Danner RL, Banks SM, Hoffman WD. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 1995; 180:286-292
22. Garzia F, Todor R, Scalea T. Continuous arteriovenous hemofiltration countercurrent dialysis (CAVH-D) in acute respiratory failure (ARDS). J Trauma 1991; 31:1277-1285
23. Gasche Y, Pascual M, Suter PM, Favre H, Chevrolet J-C, Schifferli JA. Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 1996; 11:117-119
24. Goldfarb S, Golper TA. Pro-inflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 1994; 5:228-232
25. Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73:671-685
26. Gotloib L, Barzilay E, Shustak A, Wais Z, Jaichenko J, Lev A. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 1986; 13:123-132
27. Gotloib L, Shostak, Lev A, Fudin R, Jaichenko J. Treatment of surgical and non-surgical septic multiorgan failure with bicarbonate hemodialysis and sequential hemofiltration. Intensive Care Med 1995; 21:104-111
28. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed L, van Osta G . High volume hemofiltration improves right ventricular function of endotoxin induced shock in the pig. Intensive Care Med 1992; 18:235-240
29. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed L, van Osta G. High-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 1992; 7:67-75
30. Grootendorst AF, van Bommel EFH, van Leengoed L, van Zanten A, Huipen H, Groeneveld J. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8:161-169
31. Grootendorst AF, van Bommel EF, van Leengoed LA. Nabuurs M, Bouman C, Groeneveld J . High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994; 2:72-78
32. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331:1338-1342
33. Heidemann SM, Ofenstein JP, Sarnaik AP. Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock 1994; 44:183-187
34. Hoffmann J, Hartl W, Deppisch, Faist E, Jochum M, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulary substances. Kidney International 1995; 48:1563-1570
35. Hoffman WD, Natanson C. The role of endotoxin in bacterial septic shock. in:Vincent JL (ed) Yearbook of Intensive Care and emergency medicine 1993. Springer. Berlin Heidelberg New York, 1993, pp 49-63
36. Journois D. Complement fragments and cytokines: production and removal as consequences of hemofiltration. In: Sieberth HG. Stummvoll HK, Kierdorf H (eds): Continuous extracorporeal treatment in multiple organ dysfunction syndrome. Contrib Nephrol. Basel, Karger, 1995; 116:80-85
37. Kierdorf H, Leue C. Heintz B, Riehl J, Melzer H, Sieberth HG. Continuous venovenous hemofiltration in acute renal failure: is a bicarbonate-or lactate-buffered substitution better? In: Sieberth HG, Stummvoll H, Kierdorf H (eds): Continuous extracorporeal treatment in multiple organ dysfunction syndrome. Contrib Nephrol. Basel, Karger, 1995; 116:38-47
38. Kierdorf H, Melzer H, Weissen D, Heintz B, Sieberth HG. Elimination of tumor necrosis factor by continuous venovenous hemofiltration (Abstr). Ren Fail 1992; 14:98
39. Lee PA, Matson JR, Pryor RW, Hinshaw LB. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus induced septicemia in immature swine. Crit Care Med 1993; 21:914-924
40. Lonneman G, Schindler R, Dinarello CA, Koch KM. Removal of cytokines by hemodialysis membrane in vitro. In: Faist E, Meakins J, Schildberg FW (eds) Host defense dysfunction in trauma, shock and sepsis. Springer, Berlin, Heidelber, New York, pp 613-623
41. Marangoni R, Civardi F, Masi F, Savino R, Cimino R, Colombo R, Maltagliati L. Lactate versus bicarbonate online hemofiltration: a comparative study. Artificial Organs 1995; 19:490-495
42. Millar AB, Armstrong L, van der Linden. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 56:1499-1502
43. Mink SN, Jha P, Wang R, Yang J, Bose D, Jacobs H, Light RB. Effects of continuous arteriovenous hemofiltration with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 1995; 83:178-190
44. Panichi V, Parrini M, Bianchi AM, Andreini B, Cirami C, Finato V, Palla R. Mechanisms of acid-base homeostasis in acetate and bicarbonate dialysis, lactate hemofiltration and hemodiafiltration. Int J Artif Organs 1994; 17:315-321
45. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
46. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent J-L. High-volume hemofiltration improves hemodynamics in experimental endotoxic shock. Intensive Care Med 1996; 22:S396
47. Salmon J, Cardigan R, Mackie I, Cohen SL, Machin S, Singer M. Continuous venovenous hemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways. Intensive Care Med 1997; 23:38-43
48. Sander A, Armbruster W, Sander B, Philipp Th, Schafer Ch, Thürauf N, Lange R. The influence of continuous hemofiltration on cytokine elimination and the cardiovascular stability in the early phase of sepsis. In: Sieberth HG, Stummvoll H, Kierdorf H (eds): Continuous extracorporeal treatment in multiple organ dysfunction syndrome. Contrib Nephrol. Basel, Karser, 1995; 116:99-103
49. Sato T, Orlowski JP, Zborowski M. Experimental study of extracorporeal perfusion for septic shock. ASAIO J 1993; 39: M790-M793
50. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344:570-572
51. Shoemaker WC. Circulatory mechanisms of shock and their mediators. Crit Care Med 1987; 15:787-794
52. Stein B, Pfenninger E, Grunert, Schmilz JE, Hudde M. Influence of continuous hemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive care Med 1990; 16:494-499
53. Tonnesen E, Hansen MB, Höhndorf K, Diamants M, Bendtzen K, Wanscher M, Toft P. Cytokines in plasma and ultrafiltrate during continuous aiteriovenous hemofiltration. Anaesth Intens Care 1993; 21:752-758
54. van Bommel E, Bouvy N, SO K, Vincent HH, Zietse R, Bruining HA, Weimar W. High-risk surgical acute renal failure treated by continuous arteriovenous hemodiafiltration: metabolic control and outcome in sixty patients. Nephron 1995; 70:185-192
55. van Bommel EFH, Hesse CJ, Jutte NHPM, Bruining HA, Weimar W. Cytokine kinetics (TNF-alpha, IL-1b, IL-6) during continuous hemofiltration: a laboratory and clinical study. In: Sieberth HG, Stummvoll HK, Kierdort H (eds): Continuous extracorporeal treatment in multiple organ dysfunction syndrome. Contrib Nephrol. Basel, Karger, 1995; 116:62-75
56. Vincent JL. Diagnostic and medical management/supportive care of patients with gram-negative bacteremia and septic shock. Infect Dis Clin North Am 1991; 5:807-816
57. Vincent J-L, Tielemans C. Continuous hemofiltration in severe sepsis: is it beneficial? J Crit Care 1995; 10:27-32